<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
13630-0269-4
</NDCCode>
<PackageDescription>
203 mL in 1 CAN (13630-0269-4)
</PackageDescription>
<NDC11Code>
13630-0269-04
</NDC11Code>
<ProductNDC>
13630-0269
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Australian Gold
</ProprietaryName>
<ProprietaryNameSuffix>
Spf 50
</ProprietaryNameSuffix>
<NonProprietaryName>
Avobenzone, Homosalate, Octisalate, Octocrylene
</NonProprietaryName>
<DosageFormName>
SPRAY
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20191118
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
M020
</ApplicationNumber>
<LabelerName>
Prime Packaging Inc.
</LabelerName>
<SubstanceName>
AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE
</SubstanceName>
<StrengthNumber>
25.08; 83.6; 41.8; 41.8
</StrengthNumber>
<StrengthUnit>
g/mL; g/mL; g/mL; g/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2024-09-27
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20241231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20191118
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>